Schneider Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 20-12-2024
- Paid Up Capital ₹ 0.10 M
as on 20-12-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.55 M
as on 20-12-2024
- Revenue -75.63%
(FY 2021)
- Profit 68.83%
(FY 2021)
- Ebitda 68.83%
(FY 2021)
- Net Worth -4.91%
(FY 2021)
- Total Assets -35.76%
(FY 2021)
About Schneider Lifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.55 M.
Rajesh Pandey, Sanjeev Dubey, Aditya Tripathi, and One other member serve as directors at the Company.
- CIN/LLPIN
U85300UP2016PTC083926
- Company No.
083926
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jun 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Schneider Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Pandey  | Managing Director | 09-Jun-2016 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Archana Pandey | Director | 21-Jun-2021 | Current |
| Sanjeev Dubey | Director | 27-May-2017 | Current |
| Aditya Tripathi | Director | 17-Apr-2023 | Current |
Financial Performance of Schneider Lifesciences.
Schneider Lifesciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 75.63% decrease. The company also saw a substantial improvement in profitability, with a 68.83% increase in profit. The company's net worth dipped by a decrease of 4.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Schneider Lifesciences?
In 2021, Schneider Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shreeraj Infrahousing Private LimitedActive 11 years 7 monthsRajesh Pandey and Archana Pandey are mutual person
Shreeraj Infragreen Private LimitedActive 10 years 6 monthsRajesh Pandey and Sanjeev Dubey are mutual person
- Gomtiestate Infrastructure Private LimitedActive 8 years 10 months
Rajesh Pandey and Sanjeev Dubey are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Oct 2022 | ₹1.55 M | Open |
How Many Employees Work at Schneider Lifesciences?
Unlock and access historical data on people associated with Schneider Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Schneider Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Schneider Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
